Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsConstruction in ProgressCurrent AssetsCurrent Deferred Tax AssetsCurrent Deferred Tax AssetsCurrent TaxesGoodwillGoodwill & IntangiblesLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNon-Current Deferred Tax LiabilityNotes PayablesOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Dr Reddys Laboratories (RDY) Retained Earnings (2017 - 2026)

Dr Reddys Laboratories has reported Retained Earnings over the past 9 years, most recently at $3.9 billion for Q1 2026.

  • For Q1 2026, Retained Earnings rose 5.58% year-over-year to $3.9 billion; the TTM value through Mar 2026 reached $3.9 billion, up 5.58%, while the annual FY2026 figure was $3.9 billion, 4.15% up from the prior year.
  • Retained Earnings for Q1 2026 was $3.9 billion at Dr Reddys Laboratories, up from $3.6 billion in the prior quarter.
  • Over five years, Retained Earnings peaked at $3.9 billion in Q1 2026 and troughed at $45.8 million in Q1 2022.
  • A 4-year average of $2.5 billion and a median of $3.1 billion in 2025 define the central range for Retained Earnings.
  • Biggest five-year swings in Retained Earnings: tumbled 97.86% in 2022 and later skyrocketed 5626.07% in 2023.
  • Year by year, Retained Earnings stood at $45.8 million in 2022, then skyrocketed by 5626.07% to $2.6 billion in 2023, then skyrocketed by 39.05% to $3.6 billion in 2025, then increased by 5.58% to $3.9 billion in 2026.
  • Business Quant data shows Retained Earnings for RDY at $3.9 billion in Q1 2026, $3.6 billion in Q1 2025, and $2.6 billion in Q1 2023.